Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy

Progressive Multifocal Leukoencephalopathy Clinical Trial

— LEMPMAR  

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02895581
• Other study ID #: NI_AMR_2015_1
• Status: Completed
• Phase: N/A
• First received: September 6, 2016
• Last updated: September 6, 2016
• Start date: January 2006

Study information

• Verified date: September 2016
• Source: Fondation Ophtalmologique Adolphe de Rothschild
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: The Commission nationale de l’informatique et des libertés
• Study type: Observational

Clinical Trial Summary

Retrospective medical chart review of HIV-infected patients diagnosed with progressive multifocal leukoencephalopathy

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. primary completion date: January 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• HIV infected patients

• Diagnosed with progressive multifocal leukoencephalopathy

• Minimal follow-up of one year OR patient deceased less than one year after diagnosis

Exclusion Criteria:

• Loss of follow-up within 12 months after diagnosis

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Leukoencephalopathies
• Leukoencephalopathy, Progressive Multifocal
• Progressive Multifocal Leukoencephalopathy

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rankin score		12 months after diagnosis of leukoencephalopathy	No